In our study we observed that DENA increased TNF-α levels and downregulated the expression of the TRAIL receptors (DR4 and DR5) in liver cells, leading to the establishment of a higher necrosis level and, consequently, to the induction of liver cancer. Here, TNFRSF10A is linked to liver cancer.